19 results
8-K
NARI
Inari Medical Inc
3 Aug 22
Inari Medical Announces Leadership Succession Plan
5:25pm
in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 14, 2022, under the headings “Executive … Compensation” and “Certain Relationships and Related Party Transactions,” which information is incorporated herein by reference.
The Compensation
DEFA14A
NARI
Inari Medical Inc
14 Apr 22
Additional proxy soliciting materials
4:05pm
votes on executive compensation.
NOTE: Your proxy holder will also vote on any such other business as may properly come before the meeting or any adjournment thereof.
DEF 14A
k6zjw5l
16 Apr 21
Definitive proxy
4:05pm
10-K
s5z9zv 3jpc2l4u8p12
9 Mar 21
Annual report
4:20pm
10-Q
1ohrk8nu
11 Aug 20
Quarterly report
4:07pm
424B4
jj0xhej
26 May 20
Prospectus supplement with pricing info
4:10pm
S-1/A
sq6wp94lq3
5 May 20
IPO registration (amended)
5:14pm
S-1
mqav2l4 i48q50m7
21 Feb 20
IPO registration
4:40pm
DRS/A
kwg2k6i94l05 u3ze
29 Jan 20
Draft registration statement (amended)
12:00am
DRS
u97cyv2xq9b5
19 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next